HuGE Literature Finder
Records
1
-
16
| Epigenomic charting and functional annotation of risk loci in renal cell carcinoma. Nature communications 2023 1 14 (1): 346. Nassar Amin H, Abou Alaiwi Sarah, Baca Sylvan C, Adib Elio, Corona Rosario I, Seo Ji-Heui, Fonseca Marcos A S, Spisak Sandor, El Zarif Talal, Tisza Viktoria, Braun David A, Du Heng, He Monica, Flaifel Abdallah, Alchoueiry Michel, Denize Thomas, Matar Sayed G, Acosta Andres, Shukla Sachet, Hou Yue, Steinharter John, Bouchard Gabrielle, Berchuck Jacob E, O'Connor Edward, Bell Connor, Nuzzo Pier Vitale, Mary Lee Gwo-Shu, Signoretti Sabina, Hirsch Michelle S, Pomerantz Mark, Henske Elizabeth, Gusev Alexander, Lawrenson Kate, Choueiri Toni K, Kwiatkowski David J, Freedman Matthew |
| Comprehensive analysis of lower mitochondrial complex I expression is associated with cell metastasis of clear cell renal cell carcinoma. Translational cancer research 2022 7 11 (6): 1488-1502. Zhang Futian, Hou Teng, Chen Liang, Xiong Ming, Zhou Menghao, Kazobinka Gallina, Zhao Jun, Han Xiaom |
| Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes. Frontiers in molecular biosciences 2022 9 910928. Zhang Chiyu, Huang Ruizhen, Xi Xiaoqi |
| Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy. Pathology oncology research : POR 2021 9 27 1609809. Tian Xi, Xu Wen-Hao, Wu Jun-Long, Gan Hua-Lei, Wang Hong-Kai, Gu Wei-Jie, Qu Yuan-Yuan, Zhang Hai-Liang, Ye Ding-W |
| mA RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Frontiers in oncology 2021 4 11 598017. Chen Lianze, Hu Baohui, Song Xinyue, Wang Lin, Ju Mingyi, Li Zinan, Zhou Chenyi, Zhang Ming, Wei Qian, Guan Qiutong, Jiang Longyang, Chen Ting, Wei Minjie, Zhao L |
| MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Aug . Denize Thomas, Just Pierre Alexandre, Sibony Mathilde, Blons Hélène, Timsit Marc Olivier, Drossart Tom, Jakubowicz Deborah, Broudin Chloé, Morini Aurélien, Molina Thierry, Vano Yann, Auvray-Kuentz Marie, Richard Stéphane, Mejean Arnaud, Gimenez Roqueplo Anne Paule, Burnichon Nelly, Verkarre Virgin |
| Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas. Cancer cell international 2020 6 20 235. Liu Zeyu, Wan Yuxiang, Yang Ming, Qi Xuewei, Dong Zhenzhen, Huang Jinchang, Xu Jingn |
| Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. Molecular genetics and genomics : MGG 2020 3 295 (3): 807-824. Singh Noor Pratap, Vinod P |
| In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma. Cancer medicine 2019 7 8 (12): 5760-5768. Yang Man, Hlady Ryan A, Zhou Dan, Ho Thai H, Robertson Keith |
| Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. Oncotarget 2017 1 8 (7): 11187-11198. Fabrizio Federico Pio, Costantini Manuela, Copetti Massimiliano, la Torre Annamaria, Sparaneo Angelo, Fontana Andrea, Poeta Luana, Gallucci Michele, Sentinelli Steno, Graziano Paolo, Parente Paola, Pompeo Vincenzo, De Salvo Laura, Simone Giuseppe, Papalia Rocco, Picardo Francesco, Balsamo Teresa, Flammia Gerardo Paolo, Trombetta Domenico, Pantalone Angela, Kok Klaas, Paranita Ferronika, Muscarella Lucia Anna, Fazio Vito Miche |
| Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas. Neoplasma 2016 3 63 (3): 402-10. Korabecna M, Geryk J, Hora M, Steiner P, Seda O, Tesar |
| Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma. Oncotarget 2016 12 8 (3): 5196-5205. Paulucci David J, Sfakianos John P, Skanderup Anders J, Kan Kathleen, Tsao Che-Kai, Galsky Matthew D, Hakimi A Ari, Badani Ketan |
| Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma. The American journal of surgical pathology 2015 Jul 39 (7): 889-901. Deml Karl-Friedrich, Schildhaus Hans-Ulrich, Compérat Eva, von Teichman Adriana, Storz Martina, Schraml Peter, Bonventre Joseph V, Fend Falko, Fleige Barbara, Nerlich Andreas, Gabbert Helmut E, GaBler Nikolaus, Grobholz Rainer, Hailemariam Seife, Hinze Raoul, Knüchel Ruth, Lhermitte Benoit, Nesi Gabriella, Rüdiger Thomas, Sauter Guido, Moch Holg |
| Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jan 31 (2): 181-6. Choueiri Toni K, Vaishampayan Ulka, Rosenberg Jonathan E, Logan Theodore F, Harzstark Andrea L, Bukowski Ronald M, Rini Brian I, Srinivas Sandy, Stein Mark N, Adams Laurel M, Ottesen Lone H, Laubscher Kevin H, Sherman Laurie, McDermott David F, Haas Naomi B, Flaherty Keith T, Ross Robert, Eisenberg Peter, Meltzer Paul S, Merino Maria J, Bottaro Donald P, Linehan W Marston, Srinivasan Ramapras |
| DNA hypermethylation in papillary renal cell carcinoma. BJU international 2010 6 107 (4): 664-9. Ellinger Jörg, Holl Daniel, Nuhn Philipp, Kahl Philip, Haseke Nicolas, Staehler Michael, Siegert Sabine, Hauser Stefan, Stief Christian G, Müller Stefan C, Bastian Patrick |
| CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Molecular cancer 2009 6 8 31. McRonald Fiona E, Morris Mark R, Gentle Dean, Winchester Laura, Baban Dilair, Ragoussis Jiannis, Clarke Noel W, Brown Michael D, Kishida Takeshi, Yao Masahiro, Latif Farida, Maher Eamonn |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: